News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12,361 Results
Type
Article (368)
Company Profile (1)
Press Release (11992)
Section
Business (7341)
Career Advice (7)
Deals (1009)
Drug Delivery (6)
Drug Development (888)
FDA (103)
Job Trends (299)
News (8304)
Policy (271)
Tag
Academia (13)
Accelerated approval (1)
ADA (5)
Adcomms (1)
Allergies (4)
Alliances (244)
ALS (4)
Alzheimer's disease (20)
Antibody-drug conjugate (ADC) (8)
Approvals (119)
Artificial intelligence (9)
ASCO (4)
Autoimmune disease (10)
Bankruptcy (4)
Best Places to Work (258)
Biologics (1)
Biosimilars (3)
Bladder cancer (7)
Brain cancer (3)
Breast cancer (16)
Cancer (133)
Cardiovascular disease (13)
Career advice (8)
CAR-T (2)
CDC (1)
Cell therapy (8)
Clinical research (918)
Collaboration (25)
Compensation (25)
Complete response letters (2)
COVID-19 (25)
CRISPR (6)
C-suite (12)
Cystic fibrosis (1)
Data (212)
Depression (4)
Dermatology (4)
Diabetes (34)
Diagnostics (146)
Digital health (2)
Drug discovery (5)
Drug pricing (8)
Duchenne muscular dystrophy (4)
Earnings (7820)
Editorial (1)
ESMO (5)
Events (718)
Executive appointments (2)
Eye disease (2)
FDA (256)
Funding (30)
Gene editing (8)
Gene therapy (5)
GLP-1 (32)
Government (37)
Grass and pollen (1)
Guidances (86)
Healthcare (397)
Hematology (5)
HIV (1)
IgA nephropathy (3)
Immunology and inflammation (10)
Immuno-oncology (2)
Indications (10)
Infectious disease (31)
Inflammatory bowel disease (8)
Influenza (3)
Intellectual property (6)
IPO (842)
IRA (2)
Job creations (47)
Job search strategy (7)
Kidney cancer (1)
Kidney disease (1)
Labor market (4)
Layoffs (9)
Leadership (1)
Legal (49)
Lung cancer (26)
Lymphoma (28)
Machine learning (1)
Manufacturing (20)
Marketing (1)
MASH (9)
Medical device (345)
Medtech (356)
Mergers & acquisitions (203)
Metabolic disorders (60)
mRNA (2)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (8)
Neuropsychiatric disorders (3)
Neuroscience (59)
NextGen: Class of 2026 (89)
Non-profit (41)
Now hiring (3)
Obesity (24)
Opinion (6)
Ovarian cancer (1)
Pain (11)
Pancreatic cancer (3)
Parkinson's disease (7)
Partnered (1)
Patents (8)
Patient recruitment (8)
Patient selection (1)
Peanut (1)
People (195)
Phase 1 (209)
Phase 2 (361)
Phase 3 (406)
Pipeline (724)
Policy (8)
Postmarket research (41)
Preclinical (57)
Prostate cancer (11)
Psychedelics (1)
Radiopharmaceuticals (5)
Rare diseases (21)
Real estate (49)
Regulatory (274)
Reports (3)
Research institute (15)
Resumes & cover letters (1)
RNA editing (1)
Schizophrenia (7)
Series A (2)
Series B (4)
Sickle cell disease (2)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (30)
Supply chain (1)
Tariffs (2)
The Weekly (2)
Vaccines (16)
Venture capital (2)
Weight loss (15)
Women's health (4)
Date
Today (9)
Last 7 days (19)
Last 30 days (54)
Last 365 days (894)
2026 (713)
2025 (1053)
2024 (940)
2023 (1061)
2022 (1152)
2021 (1210)
2020 (1042)
2019 (808)
2018 (686)
2017 (524)
2016 (251)
2015 (407)
2014 (257)
2013 (176)
2012 (200)
2011 (224)
2010 (258)
Location
Africa (6)
Alabama (1)
Arizona (5)
Asia (656)
Australia (74)
California (461)
Canada (116)
China (21)
Colorado (24)
Connecticut (20)
Delaware (20)
Europe (1766)
Florida (58)
Georgia (16)
Idaho (1)
Illinois (40)
India (3)
Indiana (34)
Japan (19)
Kansas (4)
Kentucky (4)
Louisiana (18)
Maine (5)
Maryland (62)
Massachusetts (338)
Michigan (9)
Minnesota (22)
Missouri (2)
Montana (1)
Nebraska (1)
Nevada (7)
New Hampshire (3)
New Jersey (155)
New York (135)
North Carolina (87)
Northern California (266)
Ohio (20)
Oklahoma (1)
Pennsylvania (124)
South America (19)
South Carolina (2)
Southern California (168)
Tennessee (9)
Texas (61)
United States (1787)
Utah (23)
Virginia (12)
Washington D.C. (2)
Washington State (48)
Wisconsin (5)
12,361 Results for "155".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
September 30, 2026
·
5 min read
Press Releases
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms
October 5, 2026
·
8 min read
Press Releases
Tasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155)
July 29, 2026
·
4 min read
Press Releases
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
April 20, 2026
·
8 min read
Press Releases
Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
April 9, 2026
·
8 min read
Press Releases
Sarah Cannon Research Institute Delivers Novel Oncology Research Insights through 155+ Accepted Abstracts & Presentations at the 2026 ASCO® Annual Meeting
May 27, 2026
·
9 min read
Press Releases
Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
June 25, 2026
·
6 min read
Press Releases
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment
July 8, 2026
·
13 min read
Press Releases
BoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight Months
March 4, 2026
·
3 min read
Press Releases
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
March 10, 2026
·
4 min read
1 of 1,237
Next
